pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›ALX-1
drug · protein
save

ALX-1

Phase 1updated 3mo ago
by Vast Therapeutics Inc🔗 ChEMBL
Phase 1
community read0 votes

Protein drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 3 investigational indications.

indications

indications
Cystic Fibrosis

targets

Parathyroid hormone/parathyroid hormone-related peptide receptor

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

trade names
Natpar, Preotact
MOA
Parathyroid hormone receptor agonist
indication
Bronchiectasis
phase
phase_1
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 2m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?